Streetbeat News

TRUP

Trupanion, Inc.

https://www.trupanion.com

Industry

Insurance - Specialty

Trupanion, Inc., together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Puerto Rico, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians. The company was formerly known as Vetinsurance International, Inc. changed its name to Trupanion, Inc. in 2013. The company was founded in 2000 and is headquartered in Seattle, Washington.

Open

49.22

Mkt cap

2.1B

Volume

72K

High

50.47

P/E Ratio

-156.94

52-wk high

57.90

Low

48.77

Div yield

N/A

52-wk low

19.69

Zeta Global Holdings Corp. (NASDAQ:ZETA) shares surged 15% in pre-market trading after reporting better-than-expected Q1 results and raising Q2 revenue guidance. Other stocks also moved significantly in pre-market trading due to various reasons including earnings reports, acquisitions, and public offerings.

Portfolio Pulse from Avi Kapoor

May 07, 2024 | 12:11 pm

AudioCodes reported disappointing Q1 earnings, leading to a significant pre-market drop in its shares. Other companies like Trupanion, Palantir Technologies, Lucid Group, Beyond, Fresenius Medical Care, Bilibili, and Gold Fields also saw their shares decline in pre-market trading due to various reasons including poor financial results and soft revenue guidance.

Portfolio Pulse from Avi Kapoor

May 07, 2024 | 9:33 am

Canaccord Genuity analyst Maria Ripps maintains a Buy rating on Trupanion (NASDAQ:TRUP) but lowers the price target from $40 to $34.

Portfolio Pulse from Benzinga Newsdesk

May 03, 2024 | 9:38 pm

Recent analyst ratings for Trupanion (NASDAQ:TRUP) show a predominantly neutral outlook, with a shift towards a more cautious stance in the last three months. Five analysts have updated their ratings, resulting in one somewhat bullish and four indifferent positions. The average 12-month price target for TRUP has been adjusted to $28.2, down from $30.60, indicating a 7.84% decrease. Analyst actions include both lowered and raised price targets, reflecting responses to market dynamics and company performance. Trupanion's financials reveal a 20.26% revenue growth rate but below-average profitability and efficiency metrics.

Portfolio Pulse from Benzinga Insights

May 03, 2024 | 8:00 pm

Piper Sandler analyst John Barnidge maintains a Neutral rating on Trupanion (TRUP) and lowers the price target from $28 to $22.

Portfolio Pulse from Benzinga Newsdesk

May 03, 2024 | 1:21 pm

Stem, Inc. reported disappointing Q1 financial results, leading to an 18.7% drop in pre-market trading. Other companies like Sprout Social, Cloudflare, and Expedia also reported underwhelming results or guidance, causing significant pre-market declines. Overall, several U.S.-listed companies experienced drops in their stock prices in pre-market trading due to poor financial performance or outlook.

Portfolio Pulse from Avi Kapoor

May 03, 2024 | 12:19 pm

Trupanion shares are trading lower following the announcement of their Q1 financial results.

Portfolio Pulse from Benzinga Newsdesk

May 03, 2024 | 10:48 am

Apple Inc. shares surged 6% in pre-market trading after announcing better-than-expected Q2 results, a $110-billion stock buyback program, and a dividend increase. Other stocks also moved significantly in pre-market trading, with notable gainers including Vaxxinity, El Pollo Loco, AXT, Inc., and Amgen Inc., each reporting positive financial results or corporate actions. Conversely, companies like NanoVibronix, Sprout Social, and Stem, Inc. saw declines due to disappointing financial results or corporate developments.

Portfolio Pulse from Avi Kapoor

May 03, 2024 | 9:57 am

Trupanion shares are trading lower following the announcement of their Q1 financial results.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 10:13 pm

Trupanion reported Q1 2024 earnings with a smaller loss per share of $(0.16) compared to the expected $(0.21), and sales of $306.121M, surpassing the forecast of $300.514M. This represents a significant improvement over the previous year, with a 73.33% decrease in losses per share and a 19.43% increase in sales.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 9:37 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.